An academic study compared MyoStrain to traditional and conventional methods of assessing heart health and researchers concluded that while traditional methods were unable to differentiate between healthy patients and asymptomatic patients at risk of heart failure, MyoStrain could.
Read More
After raising a $65M Series C round from 20 investors, CorVista, which operates in the U.S. and Canada, prepares to commercialize a system that fights heart disease.
Read More
3D interface provides cellular-level, full-body blood flow modeling to study and treat cardiovascular disease.
Read More
High-risk patients with stable heart disease may fare just as well on medications alone, versus having invasive heart operations such as stents and bypass surgeries, according to a major trial.
Read More
Circassia Pharmaceuticals, a British company with U.S. headquarters in Morrisville, has commercially launched Duaklir, a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD), in the United States.
Read More
Liquidia Technologies, Inc. will be submitting a new drug application to the Food and Drug Administration for LIQ861 early in the first quarter of 2020, according to a recent Securities and Exchange Commission filing.
Read More
As the number of American adults dying of cancer continues to decline, the number who are dying of heart disease is on the rise, according to a new report.
Read More
Rolling Stones frontman Mick Jagger is having a heart valve replaced this week, media reports say, and the star’s operation is bringing a wave of new attention to advances made in such operations.
Read More
Researchers from North Carolina State University and the University of Arizona have identified a gene associated with a common cause of heart disease in Doberman pinschers. Their findings could lead to new therapies for both dogs and humans.
Read More
